Treatment of Advanced or Recurrent Cervical Cancer with Cisplatin or Cisplatin Containing Regimens: A Cost Effective Analysis

Background: Trials have demonstrated improvements in survival with adding paclitaxel (P) or topotecan (T) to cisplatin (C) for the treatment of advanced cervical cancer. We sought to evaluate the cost effectiveness of these regimens. Methods: A decision model was developed based on Gynecologic Oncol...

Descripción completa

Detalles Bibliográficos
Autores principales: Geisler, John P., Swathirajan, Jayanth, Wood, Katherine L., Manahan, Kelly J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2012
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3520020/
https://www.ncbi.nlm.nih.gov/pubmed/23236342
http://dx.doi.org/10.7150/jca.4807

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3520020/
https://www.ncbi.nlm.nih.gov/pubmed/23236342
http://dx.doi.org/10.7150/jca.4807

Ejemplares similares